Hosted on MSN8mon
Preclinical study explores approved drug for ovarian cancer"We thought that was a perfect opportunity to try a new approach, because there is an FDA-approved iron-chelating drug called deferiprone that has been successfully used for other diseases with ...
Deferiprone is a chelating agent that binds with ferric ions (iron III) to form neutral 3:1 (deferiprone:iron) complexes that are stable over a wide range of pH values. <8yrs: not established.
Deferiprone 80mg/mL (bubble gum flavor), 100mg/mL (cherry flavor). The safety and efficacy for the treatment of transfusional iron overload in patients with myelodysplastic syndrome or with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results